Meditor Group’s Alkermes ALKS Stock Holding History

Meditor Group’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-603,790	Closed	-$12M	–	5
2020 Q4	$12M	Sell	603,790 -146,210	-19%	-$2.68M	3.35%	4
2020 Q3	$12.4M	Hold	750,000	–	–	2.78%	3
2020 Q2	$14.6M	Sell	750,000 -114,417	-13%	-$1.86M	3.05%	3
2020 Q1	$10.1M	Sell	864,417 -27,983	-3%	-$500K	3.46%	3
2019 Q4	$13.7M	Hold	892,400	–	–	3.92%	3
2019 Q3	$17.4M	Hold	892,400	–	–	4.24%	3
2019 Q2	$20.1M	Hold	892,400	–	–	4.05%	3
2019 Q1	$32.6M	Hold	892,400	–	–	6.11%	3
2018 Q4	$26.3M	Sell	892,400 -138,239	-13%	-$5.1M	5.42%	3
2018 Q3	$43.7M	Hold	1,030,639	–	–	9.4%	3
2018 Q2	$42.4M	Hold	1,030,639	–	–	8.29%	3
2018 Q1	$59.7M	Hold	1,030,639	–	–	9.4%	3
2017 Q4	$56.4M	Hold	1,030,639	–	–	7.26%	3
2017 Q3	$52.4M	Hold	1,030,639	–	–	7.95%	3
2017 Q2	$59.7M	Hold	1,030,639	–	–	8.99%	2
2017 Q1	$60.3M	Hold	1,030,639	–	–	10.78%	2
2016 Q4	$57.3M	Hold	1,030,639	–	–	14.14%	2
2016 Q3	$48.5M	Hold	1,030,639	–	–	13.42%	2
2016 Q2	$44.5M	Hold	1,030,639	–	–	18.13%	2
2016 Q1	$35.2M	Hold	1,030,639	–	–	27.95%	2
2015 Q4	$81.8M	Hold	1,030,639	–	–	39.06%	2
2015 Q3	$60.5M	Hold	1,030,639	–	–	31.89%	2
2015 Q2	$66.3M	Hold	1,030,639	–	–	45.73%	2
2015 Q1	$62.8M	Hold	1,030,639	–	–	52.74%	1
2014 Q4	$60.4M	Hold	1,030,639	–	–	62.64%	1
2014 Q3	$44.5M	Hold	1,030,639	–	–	51.62%	1
2014 Q2	$51.9M	Hold	1,030,639	–	–	38.88%	2
2014 Q1	$45.4M	Hold	1,030,639	–	–	35.61%	2
2013 Q4	$41.9M	Sell	1,030,639 -539,361	-34%	-$19.9M	30.96%	2
2013 Q3	$52.8M	Sell	1,570,000 -130,000	-8%	-$4.23M	7.44%	4
2013 Q2	$48.8M	Buy	+1,700,000	New	+$49.5M	6.6%	6

Other funds holding ALKS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Meditor Group's ALKS Position: Q1 2021 in Review

Meditor Group sold out of Alkermes (ALKS) in Q1 2021, closing a stake of 603,790 shares — an estimated $12M sold.

Meditor Group first reported a position in ALKS in Q2 2013 and held it in 31 quarters. The position peaked at $81.8M in Q4 2015. 200 funds tracked by Wall St. Rank hold ALKS as of Q1 2021.

Meditor Group reported no remaining Alkermes position as of Q1 2021 after selling out during the quarter.
Meditor Group sold 603,790 Alkermes shares in Q1 2021, an estimated $12M.
Meditor Group first reported a position in Alkermes in Q2 2013 and held it in 31 quarters.
Meditor Group's Alkermes position peaked at $81.8M in Q4 2015.
200 funds tracked by Wall St. Rank held Alkermes as of Q1 2021.

Based on Meditor Group's 13F filing for Q1 2021, filed 9 Apr 2021.